210 related articles for article (PubMed ID: 34745151)
1. CRAC Channel Controls the Differentiation of Pathogenic B Cells in Lupus Nephritis.
Li X; Zeng Q; Wang S; Li M; Chen X; Huang Y; Chen B; Zhou M; Lai Y; Guo C; Zhao S; Zhang H; Yang N
Front Immunol; 2021; 12():779560. PubMed ID: 34745151
[TBL] [Abstract][Full Text] [Related]
2. Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.
Ichinose K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Arima K; Nakamura H; Obata Y; Yamamoto K; Origuchi T; Nishino T; Kawakami A; Tsokos GC
Arthritis Rheumatol; 2016 Apr; 68(4):944-52. PubMed ID: 26636664
[TBL] [Abstract][Full Text] [Related]
3. Pim-1 as a Therapeutic Target in Lupus Nephritis.
Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Factor Erythroid 2-related Factor 2 Deficiency Exacerbates Lupus Nephritis in B6/lpr mice by Regulating Th17 Cell Function.
Zhao M; Chen H; Ding Q; Xu X; Yu B; Huang Z
Sci Rep; 2016 Dec; 6():38619. PubMed ID: 27941837
[TBL] [Abstract][Full Text] [Related]
5. ALW peptide ameliorates lupus nephritis in MRL/lpr mice.
Wang H; Lu M; Zhai S; Wu K; Peng L; Yang J; Xia Y
Arthritis Res Ther; 2019 Dec; 21(1):261. PubMed ID: 31791413
[TBL] [Abstract][Full Text] [Related]
6. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
7. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
8. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
[TBL] [Abstract][Full Text] [Related]
9. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
10. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
[TBL] [Abstract][Full Text] [Related]
11. Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model.
Zhu Y; Yue Y; Xiong S
Clin Exp Immunol; 2018 Sep; 193(3):302-312. PubMed ID: 29704464
[TBL] [Abstract][Full Text] [Related]
12. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
Ji J; Xu J; Li F; Li X; Gong W; Song Y; Dou H; Hou Y
Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):411-9. PubMed ID: 27121231
[TBL] [Abstract][Full Text] [Related]
13. Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI.
Bruschi M; Sinico RA; Moroni G; Pratesi F; Migliorini P; Galetti M; Murtas C; Tincani A; Madaio M; Radice A; Franceschini F; Trezzi B; Bianchi L; Giallongo A; Gatti R; Tardanico R; Scaloni A; D'Ambrosio C; Carnevali ML; Messa P; Ravani P; Barbano G; Bianco B; Bonanni A; Scolari F; Martini A; Candiano G; Allegri L; Ghiggeri GM
J Am Soc Nephrol; 2014 Nov; 25(11):2483-98. PubMed ID: 24790181
[TBL] [Abstract][Full Text] [Related]
14. Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice.
Hong SM; Lee J; Jang SG; Song Y; Kim M; Lee J; Cho ML; Kwok SK; Park SH
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187196
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
Wu Y; He S; Bai B; Zhang L; Xue L; Lin Z; Yang X; Zhu F; He P; Tang W; Zuo J
Cell Mol Immunol; 2016 May; 13(3):379-90. PubMed ID: 25942599
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
17. Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis.
Qi YY; Zhou XJ; Cheng FJ; Hou P; Ren YL; Wang SX; Zhao MH; Yang L; Martinez J; Zhang H
Ann Rheum Dis; 2018 Dec; 77(12):1799-1809. PubMed ID: 30209031
[TBL] [Abstract][Full Text] [Related]
18. Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
Sun J; Guo S; Niu F; Liu D; Zhuang Y
Mol Med Rep; 2020 Dec; 22(6):5436-5443. PubMed ID: 33173997
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
